TipRanks
Advertisement
Advertisement

HK:1276 Stock Latest News

Hengrui Pharma Seals Up to US$2.6 Billion Global Licensing Deal With Novo Nordisk for Oral GLP-1/GIP Drug
Company AnnouncementsHengrui Pharma Seals Up to US$2.6 Billion Global Licensing Deal With Novo Nordisk for Oral GLP-1/GIP Drug
57s ago
1276
Hengrui Pharma Clears All Resolutions at 2026 Extraordinary Shareholders’ Meeting
PremiumCompany Announcements
Hengrui Pharma Clears All Resolutions at 2026 Extraordinary Shareholders’ Meeting
5d ago
1276
Hengrui Wins NMPA Approval for New Uses of Innovative Thrombocytopenia Drug
PremiumCompany Announcements
Hengrui Wins NMPA Approval for New Uses of Innovative Thrombocytopenia Drug
19d ago
1276
Hengrui Pharmaceuticals Calls Extraordinary Meeting on New Share Schemes and Buyback Mandate
PremiumCompany Announcements
Hengrui Pharmaceuticals Calls Extraordinary Meeting on New Share Schemes and Buyback Mandate
21d ago
1276
Hengrui Pharma Sets September EGM to Approve 2026 H Share Scheme
PremiumCompany Announcements
Hengrui Pharma Sets September EGM to Approve 2026 H Share Scheme
22d ago
1276
Hengrui Pharma Wins NMPA Approval for Innovative PNH Drug
PremiumCompany AnnouncementsHengrui Pharma Wins NMPA Approval for Innovative PNH Drug
1M ago
1276
Hengrui Pharma Launches RMB1–2 Billion A-Share Buyback for Employee Ownership Plan
Premium
Company Announcements
Hengrui Pharma Launches RMB1–2 Billion A-Share Buyback for Employee Ownership Plan
1M ago
1276
Hengrui Pharma Advances 2026 Employee Stock Ownership Plan Using Existing A Shares
Premium
Company Announcements
Hengrui Pharma Advances 2026 Employee Stock Ownership Plan Using Existing A Shares
1M ago
1276
Jiangsu Hengrui Proposes 2026 H Share Incentive Scheme to Strengthen Governance
PremiumCompany Announcements
Jiangsu Hengrui Proposes 2026 H Share Incentive Scheme to Strengthen Governance
1M ago
1276
Jiangsu Hengrui Pharmaceuticals Announces Resignation of Joint Company Secretary
PremiumCompany Announcements
Jiangsu Hengrui Pharmaceuticals Announces Resignation of Joint Company Secretary
1M ago
1276
Jiangsu Hengrui Publishes Unaudited Interim Results for First Half of 2026
PremiumCompany Announcements
Jiangsu Hengrui Publishes Unaudited Interim Results for First Half of 2026
1M ago
1276
Hengrui Pharma Wins NMPA Nod for New Autoimmune Indication of Innovative Drug
PremiumCompany Announcements
Hengrui Pharma Wins NMPA Nod for New Autoimmune Indication of Innovative Drug
2M ago
1276
Hengrui Wins First-in-China Anti-HER2 Approval for Colorectal Cancer
PremiumCompany AnnouncementsHengrui Wins First-in-China Anti-HER2 Approval for Colorectal Cancer
2M ago
1276
Jiangsu Hengrui Board to Review Interim Results and Dividend in August
Premium
Company Announcements
Jiangsu Hengrui Board to Review Interim Results and Dividend in August
2M ago
1276
Hengrui Pharma Wins First China Approval for Home-Grown Long-Acting Insulin Analog
Premium
Company Announcements
Hengrui Pharma Wins First China Approval for Home-Grown Long-Acting Insulin Analog
2M ago
1276
Hengrui Wins NMPA Nod to Move Cervical Cancer Combo to First-Line Use
PremiumCompany Announcements
Hengrui Wins NMPA Nod to Move Cervical Cancer Combo to First-Line Use
2M ago
1276
Hengrui Pharma Wins NMPA Approval for First 0.1% Water-Free Cyclosporine Eye Drop in China
PremiumCompany Announcements
Hengrui Pharma Wins NMPA Approval for First 0.1% Water-Free Cyclosporine Eye Drop in China
3M ago
1276
Hengrui Wins Landmark NMPA Nod for New Lung Cancer Use of PD-L1 Drug
PremiumCompany Announcements
Hengrui Wins Landmark NMPA Nod for New Lung Cancer Use of PD-L1 Drug
3M ago
1276
Hengrui Pharma Wins NMPA Nod for New Dalpiciclib Breast Cancer Indication
PremiumCompany Announcements
Hengrui Pharma Wins NMPA Nod for New Dalpiciclib Breast Cancer Indication
3M ago
1276
Hengrui Pharma Wins NMPA Approval for First Domestic New-Generation URAT1 Inhibitor
PremiumCompany AnnouncementsHengrui Pharma Wins NMPA Approval for First Domestic New-Generation URAT1 Inhibitor
4M ago
1276
Hengrui Pharma seals global collaboration and licensing deal with Bristol-Myers Squibb
Premium
Company Announcements
Hengrui Pharma seals global collaboration and licensing deal with Bristol-Myers Squibb
5M ago
1276
Hengrui Pharma Sets Formal Remuneration and Evaluation Committee to Bolster Governance
Premium
Company Announcements
Hengrui Pharma Sets Formal Remuneration and Evaluation Committee to Bolster Governance
5M ago
1276

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >